Cargando…

Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children

BACKGROUND: Apical Membrane Antigen-1 (AMA1) is one of the leading blood stage malaria vaccine candidates. AMA1-C1/Alhydrogel® consists of an equal mixture of recombinant AMA1 from FVO and 3D7 clones of P. falciparum, adsorbed onto Alhydrogel®. A Phase 1 study in semi-immune adults in Mali showed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dicko, Alassane, Sagara, Issaka, Ellis, Ruth D., Miura, Kazutoyo, Guindo, Ousmane, Kamate, Beh, Sogoba, Moussa, Niambelé, Mohamed Balla, Sissoko, Mady, Baby, Mounirou, Dolo, Amagana, Mullen, Gregory E. D., Fay, Michael P., Pierce, Mark, Diallo, Dapa A., Saul, Allan, Miller, Louis H., Doumbo, Ogobara K.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216433/ https://www.ncbi.nlm.nih.gov/pubmed/18270560 http://dx.doi.org/10.1371/journal.pone.0001563

Ejemplares similares

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
por: Miura, Kazutoyo, et al.
Publicado: (2011)

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
por: Ellis, Ruth D, et al.
Publicado: (2011)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
por: Dicko, Alassane, et al.
Publicado: (2008)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
por: Dicko, Alassane, et al.
Publicado: (2015)

Interethnic Differences in Antigen-Presenting Cell Activation and TLR Responses in Malian Children during Plasmodium falciparum Malaria
por: Arama, Charles, et al.
Publicado: (2011)

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
por: Ouattara, Amed, et al.
Publicado: (2010)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
por: Maiga, Hamma, et al.
Publicado: (2020)

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Candidate Polymorphisms and Severe Malaria in a Malian Population
por: Toure, Ousmane, et al.
Publicado: (2012)

Patterns of malaria indices across three consecutive seasons in children in a highly endemic area of West Africa: a three times-repeated cross-sectional study
por: Ardiet, Denis-Luc, et al.
Publicado: (2014)

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
por: Kone, Aminatou, et al.
Publicado: (2020)

Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children
por: Djimde, Abdoulaye A., et al.
Publicado: (2016)

“Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”
por: Guindo, Abdoulaye, et al.
Publicado: (2019)

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
por: Gaudart, Jean, et al.
Publicado: (2006)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
por: Sagara, Issaka, et al.
Publicado: (2009)

Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults
por: Diallo, Hama, et al.
Publicado: (2019)

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
por: Laurens, Matthew B., et al.
Publicado: (2013)

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
por: Greenwood, Brian, et al.
Publicado: (2017)

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens
por: Daou, Modibo, et al.
Publicado: (2015)

A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study
por: Denoeud-Ndam, Lise, et al.
Publicado: (2015)

Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali
por: Kone, Abdoulaye K, et al.
Publicado: (2010)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
por: Travassos, Mark A., et al.
Publicado: (2015)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

First characterization of methanogens in oral cavity in Malian patients with oral cavity pathologies
por: Sogodogo, Elisabeth, et al.
Publicado: (2019)

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
por: Sagara, Issaka, et al.
Publicado: (2021)

Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact
por: Sagara, Issaka, et al.
Publicado: (2012)

X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
por: Guindo, Aldiouma, et al.
Publicado: (2007)

Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali
por: Maiga, Hamma, et al.
Publicado: (2020)

Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution
por: Diawara, Halimatou, et al.
Publicado: (2021)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
por: Woodford, John, et al.
Publicado: (2022)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study
por: Sagara, Issaka, et al.
Publicado: (2021)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
por: Dicko, Alassane, et al.
Publicado: (2010)

Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali
por: Sacko, Aissata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_045tuog154gdq0v1v5isac3n22